The Association of Community Cancer Centers (ACCC) and the Cancer Center Business Summit (CCBS) are proud to recognize the 2021-2022 Advisory Board and Task Force members for their important contributions in guiding the development of program content for the ACCC 48th Annual Meeting & Cancer Business Summit.
Nina K. Chavez, MBA, FACMPE, is VP, Value Based Care, Practice Solutions & Transformation at Flatiron Health.
Steven D'Amato, BSPharm, BCOP, is the Executive Director and clinical pharmacy specialist at New England Cancer Specialists in Scarborough, Maine. He is a clinical associate professor at the University of Tufts College of Medicine. He is a member of ASCO, ACCP, ACCC, and HOPA.
A member of the Maine Medical Center Institutional Review Board in Portland, Maine, Mr. D’Amato has 30 years of experience in clinical oncology in both the hospital and private practice settings. He has extensive knowledge of EMR implementation, utilization, and practice management.
He has lectured extensively on pain management, end-of-life care, and oncology practice. He is a board member of the Community Cancer Center in South Portland, Maine, a non-profit organization providing education and support to cancer patients.
He is a past President of the Association of Community Cancer Centers (ACCC), and is the ACCC Delegate Representative for New England Cancer Specialists. He earned his undergraduate degree from the Massachusetts College of Pharmacy in Boston, Mass.
Christian G. Downs, JD, MHA, is Executive Director of the Association of Community Cancer Centers. Mr. Downs brings more than 15 years of association management expertise, guiding associations in their work on national policy and educational programming. He has been instrumental in working with healthcare providers, the Centers for Medicare & Medicaid Services (CMS), and Congress on association–specific issues.
Mr. Downs led the Association of Community Cancer Centers' efforts on such critical issues as easing implementation of new regulations, ensuring patient access to new cancer therapies, and refining physician office payments for delivery of services.
Mr. Downs worked in the public policy department of the American Society of Clinical Oncology (ASCO) on physician office and billing and coding issues. Previously he administered a large tertiary care hospital, managed a physician multispecialty practice, and worked for the Education and Health Committee of the Virginia State Senate.
Mr. Downs received his master's degree in health administration from the Medical College of Virginia and his law degree from George Mason University with a special focus on regulatory and administrative law. He is a board member of the Patient Advocate Foundation and C–Change, a large coordinating organization for cancer groups.
Vincent M. Kickirillo is the leader of the Valuation and Transaction Advisory Services at VMG Health and is based in the Dallas office. He has over 30 years of experience providing financial, valuation, and transaction advisory services and solutions to clients in the health care industry. His clients include corporations, boards of directors, “C-level” executives and legal counsels for entities such as hospitals, health systems, ambulatory surgery centers, imaging centers, radiation therapy centers, physician practices, risk bearing entities, as well as other healthcare entities. He also has extensive experience serving Private Equity backed healthcare entities.
Prior to joining VMG Health in 2005, Mr. Kickirillo worked as a Director at FTI Consulting, Inc., a Director in KPMG’s valuation and litigation practices and in the financial advisory services practice at Ernst & Young.
Barbara L. McAneny, MD, FASCO, MACP, a board-certified medical oncologist/hematologist from Albuquerque, NM, became the 173rd president of the American Medical Association (AMA) in June 2018, serving as its chair in 2015–2016. Dr. McAneny is a fellow and former member of the board of directors of the American Society of Clinical Oncology (ASCO), a master of the American College of Physicians, and a past president of the New Mexico Medical Society (NMMS), the Greater Albuquerque Medical Association, and the New Mexico chapter of the American College of Physicians. In addition, she has served as a member of the Community Oncology Alliance Board of Trustees and on the board of directors of the Cancer Center Business Summit. She became the delegate to the AMA from ASCO in 2002 and was elected to the AMA Council on Medical Service in 2003, serving as its chair in 2009–2010.
Dr. McAneny is one of the founders and current chair of the board of the National Cancer Care Alliance, a group of independent practices collaborating to use innovation to deliver high-quality, high-value cancer care and to develop new alternative payment models based on sound data-driven principles. Prior to this, she was a founding member of Oncology Circle, a group of oncology practices using data to promote best practices. Dr. McAneny’s interest in using data to improve practice sustainability began when she was appointed to the Centers for Medicare & Medicaid Services' Practicing Physicians Advisory Council, where she served from 2002 to 2006. In 2012, Dr. McAneny received a $19.8 million grant from the Centers for Medicare & Medicaid Innovation to demonstrate how oncology practices could use triage pathways to dramatically lower costs while improving outcomes. This award, named COME HOME (for Community Oncology Medical Home), later was incorporated into Medicare’s Oncology Care Model. Dr. McAneny also cofounded New Mexico Oncology Hematology Consultants Ltd. in 1987 with Clark Haskins, MD. A managing partner since 1999, she built New Mexico Cancer Center as the first physician-owned multidisciplinary cancer center in the state with clinics in Albuquerque and Gallup. She also founded the New Mexico Cancer Center Foundation, which provides grants to help patients with non-medical expenses.
Dr. McAneny graduated magna cum laude from the University of Minnesota in 1973 and with honors from the University of Iowa College of Medicine in 1977. She completed her residency in internal medicine at the University of Iowa in 1980 and her fellowship in hematology/oncology at the University of New Mexico in 1983.
Debra Patt, MD, PhD, MBA, FASCO, is a practicing oncologist and breast cancer specialist in Austin, Texas, and an executive vice president of Texas Oncology with responsibilities in healthcare policy and strategic initiatives. Dr. Patt serves as the President of the Texas Society of Clinical Oncology, the Secretary for the Community Oncology Alliance and serves locally on the Austin Healthcare Council, Shivers Board, and formerly on the board of Komen and the Breast Cancer Resource Center. She has responsibility for breast cancer research in Austin and leads the multidisciplinary tumor boards for breast cancer. She chairs the Council on Legislation for the Texas Medical Association and works to formulate responsible healthcare policy that improves the health of Texans. She serves as the Editor in Chief of the Journal of Clinical Oncology Clinical Cancer Informatics and drives engagement in clinical informatics solutions to enhance healthcare. Within Texas Oncology, Dr. Patt serves on the payer relations, marketing, telemedicine, strategy, policy, management executive, marketing, and revenue cycle committees. She lectures medical students and is a clinical Professor at Dell Medical School at The University of Texas at Austin.
Dr. Patt received her doctorate in Health Economics and Health Services Research from The University of Texas School of Public Health, Houston, TX. She received her MBA from The University of Texas in Austin and an MPH from the University of Texas Health Science Center’s School of Public Health in Houston. Patt received her fellowship in hematology and medical oncology from The University of Texas MD Anderson Cancer Center in Houston, Texas.
Barry Russo, MBA, is the Chief Executive Officer for The Center for Cancer and Blood Disorders—a private community practice based in Fort Worth, Texas— and has been with the Center since 2002. It has over 30 providers and 200 employees across nine facilities in the Dallas-Fort Worth metropolitan area. Russo has over 30 years of healthcare experience and has worked in academic and community practices, as well as academic and community hospitals. He is a current board member of the Cancer Center Business Summit Advisory Board, a member of the board of directors for the Community Oncology Alliance (COA), an advisory board member for ReVital, and past board member for Texas MGMA. Russo is also a member of the Association of Community Cancer Centers (ACCC). He received a Master of Business Administration from the University of Dallas.
Dr. Zinkeng Asonganyi (aka “Dr Z”) oversees all facets of ambulatory practice at the University of Texas Medical Branch, including retail and specialty pharmacy services, outpatient infusion, and the integration of pharmacists into ambulatory clinics. Prior to this role, Dr. Asonganyi served as the senior pharmacy manager at Anne Arundel Medical Center (Luminis Health) in Annapolis, Maryland, overseeing the oncology department, investigational drug services, and outpatient pharmacy operations, including the development of a specialty pharmacy business. Dr. Asonganyi is an active participant in the American Society of Health System Pharmacists (ASHP) and several local pharmacy organizations.
Dr. Asonganyi is a 2012 graduate of the University of Findlay College of Pharmacy in Ohio, and he has been a health system pharmacy administrator for most of his career. He is passionate about controlling pharmaceutical expenses through supply chain and formulary management as well as revenue cycle management for both medical and pharmacy benefits.